<DOC>
	<DOCNO>NCT01267669</DOCNO>
	<brief_summary>Background : Efficacy endoscopic variceal sclerotherapy achieve initial control acute variceal bleed five-day haemostasis show significantly improve vasoactive drug add . However , limited data whether addition somatostatin , endoscopic variceal ligation ( EVL ) improve efficacy EVL . Aim : To compare EVL plus somatostatin versus EVL plus placebo control acute variceal bleeding . Patients method : Consecutive cirrhotic patient acute variceal bleed esophageal varix enrol trial . After emergency EVL , patient randomize receive either somatostatin ( 250 mcg/hr ) placebo infusion . Primary endpoint treatment failure within 5 day . Treatment failure define fresh hematemesis â‰¥2 hour start therapy death .</brief_summary>
	<brief_title>A Trial Somatostatin With Endoscopic Variceal Ligation ( EVL ) Control Acute Variceal Bleeding</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Hypertension , Portal</mesh_term>
	<mesh_term>Esophageal Gastric Varices</mesh_term>
	<mesh_term>Gastrointestinal Hemorrhage</mesh_term>
	<mesh_term>Somatostatin</mesh_term>
	<criteria>Clinical diagnosis portal hypertension Having hematemesis and/or melena within 24 hour prior admission Source bleeding esophageal varix Noncirrhotic cause portal hypertension Age &lt; 12 &gt; 75 year Hepatic encephalopathy grade 3 4 Renal failure serum creatinine &gt; 2 mg/dL Any evidence bleed additional source apart esophageal varix ( like gastric varix , portal hypertensive gastropathy , erosion ulcer include variceal ulcer ) Patients already vasoactive drug like somatostatin terlipressin current episode bleeding Patients already receive EVL EST elsewhere current episode bleed prior presenting hospital Patients history surgery portal hypertension TIPS Concomitant severe cardiopulmonary disease Concomitant malignancy HVPG possible within 24 hrs presentation Patients refuse participate study .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Variceal bleeding</keyword>
	<keyword>Endoscopic therapy</keyword>
	<keyword>Band ligation</keyword>
	<keyword>Somatostatin</keyword>
	<keyword>Vasoactive drug</keyword>
	<keyword>Octreotide</keyword>
</DOC>